Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.82 |
| ▸ | EYA2 | O00167 | 1/20 | 0.82 |
| ▸ | APP | P05067 | 1/20 | 0.82 |
| ▸ | ACE | P12821 | 1/20 | 0.82 |
| ▸ | BLM | P54132 | 2/20 | 0.78 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.78 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.78 |
| ▸ | TSHR | P16473 | 2/20 | 0.78 |
| ▸ | LMNA | P02545 | 1/20 | 0.78 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.78 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.78 |
| ▸ | DRD1 | P21728 | 1/20 | 0.78 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.78 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.78 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.78 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.78 |
| ▸ | DRD3 | P35462 | 1/20 | 0.78 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.78 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Edetic Acid SCHEMBL20955 | 1.00 | TDP1 (0.82) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL6684859 | 0.92 | TDP1 (0.70) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL1373 | 0.91 | TDP1 (1.00) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL8607480 | 0.91 | TDP1 (1.00) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL16714076 | 0.91 | TDP1 (1.00) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL3035039 | 0.91 | TDP1 (1.00) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL8624198 | 0.91 | TDP1 (1.00) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL15136 | 0.91 | TDP1 (1.00) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL16570043 | 0.90 | TDP1 (0.67) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL10542859 | 0.88 | TDP1 (0.93) | TDP1EYA2APPACEBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240200038-A1 | METHOD FOR SEPARATING AND PURIFYING INFLUENZA VIRUS-LIKE PARTICLES (VLPS) USING AQUEOUS TWO-PHASE SYSTEM (ATPS) | ZJ Huadi Pharma Group Pharma Development Co., Ltd. (CN) | 2024-06-20 | — | — | US | claimed |
| US-11926877-B2 | Saliva-based molecular testing for SARS-CoV-2 | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2024-03-12 | — | — | US | claimed |
| US-20230378297-A1 | Source/Drains In Semiconductor Devices and Methods of Forming Thereof | TAIWAN SEMICONDUCTOR MFG CO LTD (TW) | 2023-11-23 | — | — | US | claimed |
| US-11530457-B2 | Saliva-based molecular testing for SARS-CoV-2 | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2022-12-20 | — | — | US | claimed |
| WO-2021257844-A1 | SALIVA-BASED MOLECULAR TESTING FOR SARS-COV-2 | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2021-12-23 | — | — | WO | claimed |
| US-20210395839-A1 | SALIVA-BASED MOLECULAR TESTING FOR SARS-COV-2 | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2021-12-23 | — | — | US | claimed |
| EP-2300799-B1 | METHOD FOR HISTOCHEMICAL PROCESSESSING AND USE OF A COMPOSITION FOR HISTOCHEMICAL PROCESSING | VENTANA MED SYST INC (US) | 2015-11-25 | — | — | EP | claimed |
| WO-2024148013-A1 | COMPOSITIONS, KITS AND METHODS FOR DETECTION OF VIRAL SEQUENCES | Life Technologies Corporation (US) | 2024-07-11 | — | — | WO | disclosed |
| US-20240200038-A1 | METHOD FOR SEPARATING AND PURIFYING INFLUENZA VIRUS-LIKE PARTICLES (VLPS) USING AQUEOUS TWO-PHASE SYSTEM (ATPS) | ZJ Huadi Pharma Group Pharma Development Co., Ltd. (CN) | 2024-06-20 | — | — | US | disclosed |
| US-20240186188-A1 | SEMICONDUCTOR DEVICE WITH NON-CONFORMAL GATE DIELECTRIC LAYERS | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2024-06-06 | — | — | US | disclosed |
| US-11965164-B2 | Amphiphilic polynucleotides | DUKE UNIVERSITY (US) | 2024-04-23 | — | — | US | disclosed |
| US-11926877-B2 | Saliva-based molecular testing for SARS-CoV-2 | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2024-03-12 | — | — | US | disclosed |
| US-11908745-B2 | Semiconductor device with non-conformal gate dieletric layers | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2024-02-20 | — | — | US | disclosed |
| US-5958202-A | BINDING ANALYTE TO ENZYME HAVING A BIORECOGNITION MOIETY AND ELECTROPHORETIC SEPARATION, ENZYME AMPLIFIED DETECTION | PERSEPTIVE BIOSYSTEMS, INC. (US) | 1999-09-28 | — | — | US | disclosed |
| US-5922185-A | System for pH-neutral stable electrophoresis gel | NOVEL EXPERIMENTAL TECHNOLOGY, INC. (US) | 1999-07-13 | — | — | US | disclosed |
| EP-0854937-A1 | METHODS AND KIT FOR HYBRIDIZATION ANALYSIS USING PEPTIDE NUCLEIC ACID PROBES | PERSEPTIVE BIOSYSTEMS, INC. (US) | 1998-07-29 | — | — | EP | disclosed |
| WO-1997012995-A1 | METHODS AND KIT FOR HYBRIDIZATION ANALYSIS USING PEPTIDE NUCLEIC ACID PROBES | PERSEPTIVE BIOSYSTEMS, INC. (US) | 1997-04-10 | — | — | WO | disclosed |
| US-4833086-A | PLASMIDS, POLLUTION CONTROL, CULTURE OF ALCALIGENES, ETHYLENE DCHLORIDE | THE B F GOODRICH COMPANY (US) | 1989-05-23 | — | — | US | disclosed |
| US-4806482-A | CULTURING PLASMID OF ALCALIGENES; GENE ENCODING; TOXIC WASTES CONTROL; ETHYLENE DICHLORIDE | THE B.F. GOODRICH COMPANY (US) | 1989-02-21 | — | — | US | disclosed |
| EP-0241746-A2 | Microbial degradation of hydrocarbons | The B.F. GOODRICH Company (US) | 1987-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11965164-B2 | Amphiphilic polynucleotides | NCL, APLNR, POLN | TDP1 408/4885EYA2 2420/4885APP 1269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.